BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31376383)

  • 1. Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.
    Patel VM; Flanagan CE; Martins M; Jones CL; Butler RM; Woollard WJ; Bakr FS; Yoxall A; Begum N; Katan M; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2020 Feb; 140(2):380-389.e4. PubMed ID: 31376383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new tyrosine phosphorylation site in PLC gamma 1: the role of tyrosine 775 in immune receptor signaling.
    Serrano CJ; Graham L; DeBell K; Rawat R; Veri MC; Bonvini E; Rellahan BL; Reischl IG
    J Immunol; 2005 May; 174(10):6233-7. PubMed ID: 15879121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLCG1 mutations in cutaneous T-cell lymphomas.
    Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM; González-Vela C; Rubio-Camarillo M; Martín-Sánchez E; Pisano DG; Papadavid E; Papadaki T; Requena L; García-Marco JA; Méndez M; Provencio M; Hospital M; Suárez-Massa D; Postigo C; San Segundo D; López-Hoyos M; Ortiz-Romero PL; Piris MA; Sánchez-Beato M
    Blood; 2014 Mar; 123(13):2034-43. PubMed ID: 24497536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gain-of-function variation in PLCG1 causes a new immune dysregulation disease.
    Tao P; Han X; Wang Q; Wang S; Zhang J; Liu L; Fan X; Liu C; Liu M; Guo L; Lee PY; Aksentijevich I; Zhou Q
    J Allergy Clin Immunol; 2023 Nov; 152(5):1292-1302. PubMed ID: 37422272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
    Tensen CP
    J Invest Dermatol; 2015 Sep; 135(9):2153-2154. PubMed ID: 26269406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
    Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
    Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A frequent PLCγ1 mutation in adult T-cell leukemia/lymphoma determines functional properties of the malignant cells.
    Prawiro C; Bunney TD; Kampyli C; Yaguchi H; Katan M; Bangham CRM
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166601. PubMed ID: 36442790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway.
    Altman A; Kaminski S; Busuttil V; Droin N; Hu J; Tadevosyan Y; Hipskind RA; Villalba M
    Eur J Immunol; 2004 Jul; 34(7):2001-11. PubMed ID: 15214048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
    Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
    Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
    Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
    Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.
    Ngaotepprutaram T; Kaplan BL; Kaminski NE
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):209-18. PubMed ID: 23999542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance.
    Fu G; Chen Y; Yu M; Podd A; Schuman J; He Y; Di L; Yassai M; Haribhai D; North PE; Gorski J; Williams CB; Wang D; Wen R
    J Exp Med; 2010 Feb; 207(2):309-18. PubMed ID: 20123962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
    Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
    J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
    Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.
    Jutz S; Leitner J; Schmetterer K; Doel-Perez I; Majdic O; Grabmeier-Pfistershammer K; Paster W; Huppa JB; Steinberger P
    J Immunol Methods; 2016 Mar; 430():10-20. PubMed ID: 26780292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways.
    Fiebich BL; Collado JA; Stratz C; Valina C; Hochholzer W; Muñoz E; Bellido LM
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):98-106. PubMed ID: 21631396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome.
    Kim EJ; Lewis DJ; Duvic M
    J Invest Dermatol; 2017 Sep; 137(9):1831-1833. PubMed ID: 28843295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through Src-family kinases.
    Peng WY; Abere B; Shi H; Toland S; Smithgall TE; Moore PS; Chang Y
    Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2316467120. PubMed ID: 38079542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
    Butler RM; McKenzie RC; Jones CL; Flanagan CE; Woollard WJ; Demontis M; Ferreira S; Tosi I; John S; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2019 Sep; 139(9):1975-1984.e2. PubMed ID: 30910759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.